On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...